» Articles » PMID: 21353552

Endocrine Aspects of Duchenne Muscular Dystrophy

Overview
Specialty Neurology
Date 2011 Mar 1
PMID 21353552
Citations 23
Authors
Affiliations
Soon will be listed here.
Citing Articles

Early Cardiac Dysfunction in Duchenne Muscular Dystrophy: A Case Report and Literature Update.

Lupu M, Pintilie I, Teleanu R, Marin G, Vladacenco O, Severin E Int J Mol Sci. 2025; 26(4).

PMID: 40004149 PMC: 11855830. DOI: 10.3390/ijms26041685.


Is endocrine surveillance important in the care of Duchenne Muscular Dystrophy? Results from a national survey to patients and families on endocrine complications.

Galetaki D, Szymczuk V, Shi M, Merchant N eNeurologicalSci. 2024; 36:100513.

PMID: 38989274 PMC: 11231648. DOI: 10.1016/j.ensci.2024.100513.


Humanization of the mdx Mouse Phenotype for Duchenne Muscular Dystrophy Modeling: A Metabolic Perspective.

Donen G, Milad N, Bernatchez P J Neuromuscul Dis. 2023; 10(6):1003-1012.

PMID: 37574742 PMC: 10657711. DOI: 10.3233/JND-230126.


The Importance of Implementing a Transition Strategy for Patients with Muscular Dystrophy: From Child to Adult-Insights from a Tertiary Centre for Rare Neurological Diseases.

Lupu M, Ioghen M, Perjoc R, Scarlat A, Vladacenco O, Roza E Children (Basel). 2023; 10(6).

PMID: 37371191 PMC: 10296957. DOI: 10.3390/children10060959.


Growth hormone secretagogues modulate inflammation and fibrosis in mouse model of Duchenne muscular dystrophy.

Boccanegra B, Cappellari O, Mantuano P, Trisciuzzi D, Mele A, Tulimiero L Front Immunol. 2023; 14:1119888.

PMID: 37122711 PMC: 10130389. DOI: 10.3389/fimmu.2023.1119888.